Citation Impact
Citing Papers
Tissue-Wide Expression Profiling Using cDNA Subtraction and Microarrays to Identify Tumor-Specific Genes
2004
Species-Specific Recognition of Single-Stranded RNA via Toll-like Receptor 7 and 8
2004 StandoutScience
Innate Antiviral Responses by Means of TLR7-Mediated Recognition of Single-Stranded RNA
2004 StandoutScience
CpG Motifs in Bacterial DNA Activate Leukocytes Through the pH-Dependent Generation of Reactive Oxygen Species
1998
Using a microfluidic device for 1 l DNA microarray hybridization in 500 s
2005
Spontaneous and Cationic Lipid-Mediated Uptake of Antisense Oligonucleotides in Human Monocytes and Lymphocytes
1998
Nanomaterials with enzyme-like characteristics (nanozymes): next-generation artificial enzymes
2013 Standout
Multiple Mechanisms May Contribute to the Cellular Anti-Adhesive Effects of Phosphorothioate Oligodeoxynucleotides
1996
Designing materials for biology and medicine
2004 StandoutNature
A Toll-like receptor recognizes bacterial DNA
2000 StandoutNature
Centrosome Amplification and a Defective G2–M Cell Cycle Checkpoint Induce Genetic Instability in BRCA1 Exon 11 Isoform–Deficient Cells
1999
Antisense technologies
2003
Binding, uptake, and intracellular trafficking of phosphorothioate-modified oligodeoxynucleotides.
1995
Cell-cycle checkpoints and cancer
2004 StandoutNature
TLR-dependent and TLR-independent pathways of type I interferon induction in systemic autoimmunity
2007 StandoutNobel
Potent 2'-Amino-2'-deoxypyrimidine RNA Inhibitors of Basic Fibroblast Growth Factor
1995
Genetic analysis of resistance to viral infection
2007 StandoutNobel
Regulation of DNA repair in hypoxic cancer cells
2007
Oligodeoxynucleotide Modifications Determine the Magnitude of B Cell Stimulation by CpG Motifs
1996
Progress in Antisense Oligonucleotide Therapeutics
1996
Innovative nanotechnologies for the delivery of oligonucleotides and siRNA
2006
CpG motifs in bacterial DNA trigger direct B-cell activation
1995 StandoutNature
Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy
2005 StandoutNature
Neural-Tube Defects
1999 Standout
The Breast Cancer Susceptibility Gene BRCA1 Is Required for Subnuclear Assembly of Rad51 and Survival following Treatment with the DNA Cross-linking Agent Cisplatin
2000
Cells on chips
2006 StandoutNature
Systemic delivery of morpholino oligonucleotide restores dystrophin expression bodywide and improves dystrophic pathology
2006 StandoutNobel
hCds1-mediated phosphorylation of BRCA1 regulates the DNA damage response
2000 Nature
Intracellular Toll-like Receptors
2010 StandoutNobel
Hypoxia Inhibits G1/S Transition through Regulation of p27 Expression
2001 StandoutNobel
Antisense Oligonucleotides as Therapeutic Agents—Is the Bullet Really Magical?
1993 Science
Budding Yeast Rad9 Is an ATP-Dependent Rad53 Activating Machine
2001
Direct Immunologic activities of CpG DNA and implications for gene therapy
1999
Computational design of trimeric influenza-neutralizing proteins targeting the hemagglutinin receptor binding site
2017 StandoutNobel
Antisense Oligonucleotide Down-Regulation of E-Cadherin in the Yolk Sac and Cranial Neural Tube Malformations1
1995
Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies
2011 Standout
Impact of the cyclin–dependent kinase inhibitor p27Kip1 on resistance of tumor cells to anticancer agents
1996
Oligonucleotide N3'-->P5' phosphoramidates as antisense agents
1996
Bacterial CpG DNA Activates Immune Cells to Signal Infectious Danger
1999
Morpholino Antisense Oligomers: Design, Preparation, and Properties
1997
Lack of Immune Stimulation by Immobilized CpG-Oligodeoxynucleotide
1999
Phosphorothioate Oligodeoxynucleotides Inhibit Basic Fibroblast Growth Factor-Induced AngiogenesisIn VitroandIn Vivo
1999
The DNA damage response: putting checkpoints in perspective
2000 StandoutNature
Revealing the world of RNA interference
2004 StandoutNatureNobel
Functions of the BRCA1 and BRCA2 genes
1998
Regulation of chromatin structure by site-specific histone H3 methyltransferases
2000 StandoutNature
The Unc93b1 mutation 3d disrupts exogenous antigen presentation and signaling via Toll-like receptors 3, 7 and 9
2006 StandoutNobel
Collaboration of Brca1 and Chk2 in tumorigenesis
2004
Stereo-enriched phosphorothioate oligodeoxynucleotides: synthesis, biophysical and biological properties
2000
Oxygen Sensing, Homeostasis, and Disease
2011 StandoutNobel
Isolation and structure of the endogenous agonist of opioid receptor-like ORL1 receptor
1995 StandoutNature
Chromatin–IgG complexes activate B cells by dual engagement of IgM and Toll-like receptors
2002 StandoutNature
Genes that mediate breast cancer metastasis to lung
2005 StandoutNature
A Sense Phosphorothioate Oligonucleotide Directed to the Initiation Codon of Transcription Factor NF-κ-B Causes Sequence-Specific Immune Stimulation
1993
Influence of Base Composition on Membrane Binding and Cellular Uptake of 10-mer Phosphorothioate Oligonucleotides in Chinese Hamster Ovary (CHRC5) Cells
1994
Defining the role of hypoxia-inducible factor 1 in cancer biology and therapeutics
2009 StandoutNobel
Antisense oligonucleotide strategies in neuropharmacology
1994
Immobilizing affinity proteins to nitrocellulose: a toolbox for paper-based assay developers
2015 StandoutNobel
Pathogen Recognition and Innate Immunity
2006 Standout
Comparison of Cellular Binding and Uptake of Antisense Phosphodiester, Phosphorothioate, and Mixed Phosphorothioate and Methylphosphonate Oligonucleotides
1993
Suppression of the coffee-ring effect by shape-dependent capillary interactions
2011 StandoutNature
Establishing Microporosity in Open Metal−Organic Frameworks: Gas Sorption Isotherms for Zn(BDC) (BDC = 1,4-Benzenedicarboxylate)
1998 StandoutNobel
Stage-specific oligonucleotide uptake in murine bone marrow B-cell precursors
1994
Structure of an XRCC1 BRCT domain: a new protein-protein interaction module
1998 StandoutNobel
Rapid induction of mitogen-activated protein kinases by immune stimulatory CpG DNA.
1998
Assembly of Metal−Organic Frameworks from Large Organic and Inorganic Secondary Building Units: New Examples and Simplifying Principles for Complex Structures
2001 StandoutNobel
Phosphorodithioate DNA as a Potential Therapeutic Drug
1993 Science
Nucleic Acid Selection and the Challenge of Combinatorial Chemistry
1997
Antagonism of Immunostimulatory CpG-Oligodeoxynucleotides by Quinacrine, Chloroquine, and Structurally Related Compounds
1998
RNA-peptide fusions for the in vitro selection of peptides and proteins
1997 StandoutNobel
Antagonism of Immunostimulatory CpG-Oligodeoxynucleotides by 4-Aminoquinolines and Other Weak Bases: Mechanistic Studies
1999
Immobilization of single-stranded DNA fragments to solid surfaces and their repeatable specific hybridization: covalent binding or adsorption?
2004
Regulation of in vitro gene expression using antisense oligonucleotides or antisense expression plasmids transfected using starburst PAMAM dendrimers
1996
Sequence-independent induction of Sp1 transcription factor activity by phosphorothioate oligodeoxynucleotides.
1994
Construction of Porous Solids from Hydrogen-Bonded Metal Complexes of 1,3,5-Benzenetricarboxylic Acid
1996 StandoutNobel
Progress in the Delivery of Therapeutic Oligonucleotides: Organ/Cellular Distribution and Targeted Delivery of OligonucleotidesIn Vivo
2003
Cutting Edge: Rapid Induction of Mitogen-Activated Protein Kinases by Immune Stimulatory CpG DNA
1998
Fullerene–Oligonucleotide Conjugates: Photoinduced Sequence‐Specific DNA Cleavage
1995
Antisense Oligonucleotides: Promise and Reality
2001
G Protein-Coupled Receptors: Functional and Mechanistic Insights Through Altered Gene Expression
1998 StandoutNobel
CpG Motifs in Bacterial DNA and Their Immune Effects
2002 Standout
Antisense oligodeoxynucleotide phosphorothioate complementary to Gag mRNA blocks replication of human immunodeficiency virus type 1 in human peripheral blood cells.
1994
Selective Covalent Protein Immobilization: Strategies and Applications
2009
Hybridization Enhancement Using Cavitation Microstreaming
2003
Nanomaterials with enzyme-like characteristics (nanozymes): next-generation artificial enzymes (II)
2018 Standout
A Pictet-Spengler ligation for protein chemical modification
2012 StandoutNobel
A Field Guide to Foldamers
2001 Standout
About Dendrimers: Structure, Physical Properties, and Applications
1999 Standout
Selective Guest Binding by Tailored Channels in a 3-D Porous Zinc(II)−Benzenetricarboxylate Network
1997 StandoutNobel
Carbon Nanomaterials for Biological Imaging and Nanomedicinal Therapy
2015 Standout
Modular Chemistry: Secondary Building Units as a Basis for the Design of Highly Porous and Robust Metal−Organic Carboxylate Frameworks
2001 StandoutNobel
The Role of Cell Surface Receptors in the Activation of Human B Cells by Phosphorothioate Oligonucleotides
2000
Oligonucleotide uptake in human hematopoietic cells is increased in leukemia and is related to cellular activation
1996
In Vitro Selection of Functional Nucleic Acids
1999 StandoutNobel
Oligodeoxyribonucleotide Uptake in Primary Human Hematopoietic Cells Is Enhanced by Cationic Lipids and Depends on the Hematopoietic Cell Subset
1998
Magnetic Nanoparticles: Design and Characterization, Toxicity and Biocompatibility, Pharmaceutical and Biomedical Applications
2012 Standout
Oligonucleotide-Modified Gold Nanoparticles for Intracellular Gene Regulation
2006 StandoutScience
HIV-1-infected monocyte-derived dendritic cells do not undergo maturation but can elicit IL-10 production and T cell regulation
2004 StandoutNobel
Identification and characterization of a cell membrane nucleic acid channel
1998
T-Shaped Molecular Building Units in the Porous Structure of Ag(4,4‘-bpy)·NO3
1996 StandoutNobel
CpG-DNA-specific activation of antigen-presenting cells requires stress kinase activity and is preceded by non-specific endocytosis and endosomal maturation
1998
Molecular Mechanisms of Mammalian DNA Repair and the DNA Damage Checkpoints
2004 StandoutNobel
Suprasupermolecules with Novel Properties: Metallodendrimers
1999 Standout
Works of John L. Tonkinson being referenced
Binding of phosphorothioate oligodeoxynucleotides to basic fibroblast growth factor, recombinant soluble CD4, laminin and fibronectin is P-chirality independent
1995
Stimulation of Calcium Influx in HL60 Cells by Cholesteryl-Modified Homopolymer Oligodeoxynucleotides
1992
Patterns of intracellular compartmentalization, trafficking and acidification of 5×-fluorescein labeled phosphodiester and phosphorothioate oligodeoxynucleotides in HL60 cells
1994
Dynamics of the internalization of phosphodiester oligodeoxynucleotides in HL60 cells
1993
Phosphorothioate oligodeoxynucleotides—anti-sense inhibitors of gene expression?
1991
New Drugs: Antisense Oligodeoxynucleotides as Clinical Therapeutic Agents
1996
Phosphorothioate Oligodeoxynucleotides Bind to Basic Fibroblast Growth Factor, Inhibit Its Binding to Cell Surface Receptors, and Remove It from Low Affinity Binding Sites on Extracellular Matrix
1995
Cellular Pharmacology and Protein Binding of Phosphoromonothioate and Phosphorodithioate Oligodeoxynucleotides: A Comparative Study
1994
Nitrocellulose a tried and true polymer finds utility as a post-genomic substrate
2002
Expression Microarray Hybridization Kinetics Depend on Length of the Immobilized DNA but Are Independent of Immobilization Substrate
2001
Modification of antisense phosphodiester oligodeoxynucleotides by a 5' cholesteryl moiety increases cellular association and improves efficacy.
1993
A BRCA1 mutant alters G2-M cell cycle control in human mammary epithelial cells.
1997
Induction of phosphorylation on BRCA1 during the cell cycle and after DNA damage.
1997
FAST TM Slides: A Novel Surface for Microarrays
2000